Overview

Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Blinded withdrawal of regular co-medication with paracetamol in chronic pain patients under strong opioids on pain control.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Inselspital, Berne
Collaborator:
Swiss National Science Foundation
Treatments:
Acetaminophen